Global Sleep Apnea Devices Market By Device Type (Therapeutic Devices and Diagnostic Devices), By End-User (Sleep Laboratories & Hospitals, and Home Care Settings), By Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023 – 2032

Report Overview

In 2022, the Global Sleep Apnea Devices Market was valued at USD 8.1 Billion. This Market is estimated to reach USD 16.0 Billion in 2032 at the highest CAGR of 7.2% between 2023 and 2032.

Sleep apnea devices are machines that are used to help the user to keep breathing airways open while sleeping. It uses mild air pressure to help the user breathe while sleeping.

Sleep apnea devices are generally prescribed by professionals to individuals having sleep-related breathing disorders. Sleep apnea is a disorder that includes breathing problems during sleep. Sleep apnea devices are used in the treatment of different sleep apnea types, like obstructive sleep apnea and central sleep apnea.

According to chest physicians in the U.S., in 2019, 170 million individuals were diagnosed with obstructive sleep apnea. Therefore, the rising prevalence of sleep apnea has increased the demand for sleep apnea devices.

The geriatric population is found to be more susceptible to sleep apnea disorders. Many individuals across the world are still unaware of the sleep apnea disorders like obstructive sleep apnea. It is directly affecting the life expectancy of the geriatric population. With the increasing life expectancy of the geriatric population, sleep apnea devices are also expected to experience significant growth in the market.

*Actual Numbers Might Vary In The Final Report

Key Takeaways

• In 2022, the Sleep Apnea Devices Market was valued at USD 8.1 Billion.
• This market is estimated to reach USD 16.0 Billion by 2032.
• The sleep apnea devices market is projected to grow at a CAGR of 7.2% from 2023-2032.
• In 2019, 170 million individuals in the U.S. were diagnosed with obstructive sleep apnea.
• Almost 40% of the obese population across the world has sleep apnea.
• Among those with sleep apnea, approximately 70% are obese.
• The average cost of sleep apnea devices like CPAP and PSG in the U.S. is between USD 600 to USD 800.
• Therapeutic devices dominate the global sleep apnea devices market with a revenue share of 76.8%.
• North America holds a major revenue share in the global sleep apnea devices market at 47.6%.
• According to the American Academy of Sleep Medicine, 2-5% of women and 3-7% of men globally have sleep apnea.
• The therapeutic devices segment in the sleep apnea devices market has subtypes, including nasal devices, oral devices, positive airway pressure (PAP) devices, and chin straps.
• The diagnostic devices segment in the sleep apnea devices market includes respiratory polygraphs, polysomnography (PSG) devices, actigraphs, and pulse oximeters.
• In the global sleep apnea devices market, sleep laboratories & hospitals lead in terms of end-users.
• In November 2022, ResMed partnered with Alphabet’s life science offshoot Verily.

Driving Factor

Rising Awareness about Sleep Apnea Disorders is Expected to Boost the Growth of the Global Sleep Apnea Devices Market.

Rising awareness about sleep apnea disorders like obstructive sleep apnea among individuals across the world is the primary factor for the growth of the global sleep apnea devices market. Many individuals across the world are still unaware of sleep apnea disorders. Therefore, to increase awareness about sleep apnea, many governmental and non-governmental organizations are taking various initiatives to spread awareness about sleep apnea disorders.

According to the American Heart Association, many cross-sectional studies have estimated that sleep apnea is present in almost 40% of the obese population across the world, and 70% of these individuals with sleep apnea disorder are obese. This increasing number of sleep apnea disorders among the obese population is also expected to propel the growth of the sleep apnea devices market. ll these key factors are fueling the growth of the global sleep apnea devices market.

Restraining Factor

The High Cost of Sleep Apnea Devices is Restricting Many Individuals from Adoption of These Devices.

The rising awareness of sleep apnea is encouraging many individuals to adopt sleep apnea devices. However, the high price of sleep apnea treatments and sleep apnea devices is restricting a major part of the population from adopting sleep apnea devices. The sleep apnea devices like CPAP (Continuous Positive Airway Pressure) and PSG (Polysomnography) are the most preferred devices for sleep apnea, like obstructive sleep apnea.

These devices average cost around USD 600 to USD 800 in . S.U.S., that too without medical insurance. However, developing countries like India lack the developed infrastructure for the development of sleep apnea devices. This increases the cost of devices within the country. These key factors are expected to hinder the growth of the global sleep apnea market over the forecast period.

By Device Type Analysis

Rising Awareness About Sleep Apnea Disorders is Driving the Growth of Therapeutic Devices in the Devices Type Segment of the Global Sleep Apnea Devices Market.

Based on device type, the global sleep apnea market is classified into therapeutic devices and diagnostic devices. These devices are further classified into subtypes like therapeutic devices are further classified into nasal devices, oral devices, positive airway pressure (PAP) devices, and chin straps. The diagnostic devices are further classified into respiratory polygraphs, polysomnography (PSG) devices, actigraphs, and pulse oximeters.

From these device types, therapeutic devices hold a major revenue share of 76.8% to dominate the segment in the global sleep apnea devices market. The rising awareness about obstructive sleep apnea is primarily driving the growth of therapeutic devices in the device type segment. Rising government initiatives and advancements in sleep apnea devices are also propelling the growth of therapeutic devices in the device type segment of the global sleep apnea devices market.

By End-User Analysis

High Usage and Increasing Research and Development Activities are Driving the Growth of Sleep Laboratories & Hospitals in the Global Sleep Apnea Devices Market.

Based on end-users, the global sleep apnea market is classified into sleep laboratories & hospitals, and home care settings. Out of these end-users, the sleep laboratories & hospitals lead the segment by covering the major revenue share in the account.

This growth of sleep laboratories & hospitals is owing to the high usage of sleep apnea devices in the sleep laboratories & hospitals and extended research facilities. The governments of many countries are investing in the healthcare sector for advancements in the technologies used in the healthcare sector. These key factors are driving the growth of sleep laboratories & hospitals in the end-user segment of the global apnea devices market.

Market Segments

By Device Type

• Therapeutic Devices
  • Nasal Devices
  • Oral Devices
  • Positive Airway Pressure (PAP) Devices
  • Chin Straps
• Diagnostic Devices
  • Respiratory Polygraphs
  • Polysomnography (PSG) Device
  • Actigraphs
  • Pulse Oximeters

By End-User

• Sleep Laboratories & Hospitals
• Home Care Settings

Growth Opportunity

Increasing Research and Development Activities from Key Players in the Market are Expected to Create Many Opportunities in the Market Over the Forecast Period.

The key players in the global sleep apnea devices market are heavily investing in the research and development of efficient sleep apnea devices that can exclude the need for constant monitoring of sleep apnea devices by professionals. Sleep apnea devices require constant medical supervision and consistent use for expected effects.

Therefore, key companies are focusing on the development of more efficient devices that can drop the involvement of medical supervision. This is expected to create many opportunities in the global sleep apnea devices market during the forecast period. Also, the governments of many countries are heavily investing in the development of healthcare infrastructure within the countries. This is anticipated to positively affect the growth of the global sleep apnea devices Market over the forecast period.

Latest Trends

The Rising Adoption of Advance Seep Apnea Devices is Anticipated to Boost the Growth of the Global Sleep Apnea Market During the Forecast Period.

The changing preferences of patients from traditional sleep apnea devices to technologically advanced devices are boosting the growth of the sleep apnea devices market. Many patients to prefer adopt mandibular advanced devices (MAD) over continuous positive airway pressure (CPAP) for obstructive sleep apnea treatment.

This shift of preferences from the patients is due to discomfort and complications caused by continuous positive airway pressure. The number of patients adopting CPAP has reduced significantly in the last few years due to the introduction of other alternatives like oral appliances. ll these factors are expected to positively affect the global sleep apnea devices market over the forecast period.

Regional Analysis

North America Leads the Global Sleep Apnea Market by Covering the Major Revenue Share.

North America dominates the global sleep apnea devices market by holding a major revenue share of 47.6%. This massive growth of the North American region is due to the developed healthcare infrastructure in the region. Countries like the United States and Canada are home to many major companies in the sleep apnea devices market due to improved healthcare structures within the region.

According to the American Academy of Sleep Medicine, 2-5% of women and 3-7% of men have sleep apnea across the world. With rising awareness of sleep apnea among individuals, the demand for sleep apnea devices is also rising significantly in the region. This is propelling the growth of the sleep apnea devices market in the North American region. Also, the increasing disposable incomes and prevalence of various respiratory devices are also acting as key factors in the growth of the sleep apnea devices market in the North American region.

After North America, Asia Pacific is expected to grow at a significant CAGR during the forecast period. The growing geriatric population and an increasing number of patients with breathing disorders are driving the growth of the sleep apnea devices market in the Asia Pacific region.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Player Analysis

The global sleep apnea devices market is classified into many companies offering the product. Key companies are focusing on the development of new and innovative products in the Market to expand their market share. Many major companies are adopting various business strategies like acquisition, mergers, collaboration, and partnership to expand their market share over new regions and strengthen their position in the Market.

Some of the key players in the global sleep apnea devices market are Phillips Respironics, Fisher & Paykel Healthcare Limited, ResMed, Invacare Corporation, Somnetics International, Inc., BMC Medical Co. Ltd., Natus Medical Incorporated, Compumedics Limited, Itamar Medical Ltd., Nihon Kohden Corporation, E.G.E. Healthcare, and other key players.

Top Key Players

• Phillips Respironics
• Fisher & Paykel Healthcare Limited
• ResMed
• Invacare Corporation
• Somnetics International, Inc.
• BMC Medical Co. Ltd.
• Natus Medical Incorporated
• Compumedics Limited
• Itamar Medical Ltd.
• Nihon Kohden Corporation
• .E.G.E. Healthcare
• Other Key Players

Recent Developments

• In August 2021, Vivos Therapeutics Inc and Empower Sleep Collaborated to improve the obstructive sleep apnea diagnosis and treatment significantly.
• In November 2022, ResMed and Alphabet’s life science offshoot Verily formed the end-to-end solution for employers and healthcare providers to identify the risk of complex sleep disorders.

Report Scope